|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, December 12, 2016 ) According to Publisher, the Veterinary Anti-infectives market is accounted for $4.79 billion in 2015 and is expected to reach $9.11 billion by 2022 growing at a CAGR of 9.6% from 2015 to 2022. Growing zoonotic and foodborne diseases and greater livestock production are the key factors fueling the market growth. Increased competition for cultivated land and cost effective production are the major factors that are hampering the market growth. On the other hand, with constant innovation and quick technological advancements, the probability of decreasing the cost of anti-infective drugs is high.
For more information about this report: http://www.reportsweb.com/veterinary-antiinfectives-global-market-outlook-2015-2022 .
Some of the key players in the market include Novartis Animal Health, Inc., Virbac, Boehringer Ingelheim, Zoetis, Ceva Animal Health, Bayer healthcare, Heska Corporation, Merial Animal Health, Bioniche Animal Health Canada, Inc., Merck & Co., Inc.,Sanofi-Aventis, Pfizer Inc. and Elanco.
Species Covered:
-Farm animal
-Poultry
-Sheep
-Cattle
-Fish
-Swine
-Companion Animals
-Horses
-Dogs
-Cats
Disease Covered:
-Beta-lactams
-Marbofloxacine
-Amminosidin
-Freeze-dried ceftiofur
-Oxytetracycline
-Florfenicol
Regions Covered:
-North America
-US
-Canada
-Mexico
-Europe
-Germany
-France
-Italy
-UK
-Spain
-Rest of Europe
-Asia Pacific
-Japan
-China
-India
-Australia
-New Zealand
-Rest of Asia Pacific
-Rest of the World
-Middle East
-Brazil
-Argentina
-South Africa
-Egypt
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001322780/sample .
What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
9 Company Profiling
9.1 Novartis Animal Health, Inc.
9.2 Virbac
9.3 Boehringer Ingelheim
9.4 Zoetis
9.5 Ceva Animal Health
9.6 Bayer healthcare
9.7 Heska Corporation
9.8 Merial Animal Health
9.9 Bioniche Animal Health Canada, Inc.
9.10 Merck & Co., Inc.,
9.11 Sanofi-Aventis
9.12 Pfizer Inc.
9.13 Elanco
Inquire before Buying at http://www.reportsweb.com/inquiry&RW0001322780/buying .
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
